share_log

Reneo Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-OCTAGON CAPITAL ADVISORS LP(6.75%),OCTAGON INVESTMENTS MASTER FUND LP(6.75%), etc.

SEC announcement ·  Feb 5 16:05
Summary by Moomoo AI
On December 31, 2023, a Schedule 13G filing was made with the United States Securities and Exchange Commission by Octagon Capital Advisors LP, Octagon Investments Master Fund LP, and Ting Jia, collectively holding a 6.75% stake in Reneo Pharmaceuticals, Inc. The filing indicates that Octagon Capital Advisors LP, a Delaware limited partnership, and Octagon Investments Master Fund LP, an exempted limited partnership established in the Cayman Islands, are managed by Ting Jia, who is also the principal beneficial owner. The shares are held for investment purposes, and the filing asserts that the acquisition of the shares does not aim to change the control of Reneo Pharmaceuticals. The 2,250,000 common shares owned represent a significant investment in the company, based on the total number of shares outstanding as reported in Reneo Pharmaceuticals' Form 10-Q filed on November 13, 2023.
On December 31, 2023, a Schedule 13G filing was made with the United States Securities and Exchange Commission by Octagon Capital Advisors LP, Octagon Investments Master Fund LP, and Ting Jia, collectively holding a 6.75% stake in Reneo Pharmaceuticals, Inc. The filing indicates that Octagon Capital Advisors LP, a Delaware limited partnership, and Octagon Investments Master Fund LP, an exempted limited partnership established in the Cayman Islands, are managed by Ting Jia, who is also the principal beneficial owner. The shares are held for investment purposes, and the filing asserts that the acquisition of the shares does not aim to change the control of Reneo Pharmaceuticals. The 2,250,000 common shares owned represent a significant investment in the company, based on the total number of shares outstanding as reported in Reneo Pharmaceuticals' Form 10-Q filed on November 13, 2023.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more